{
    "Trade/Device Name(s)": [
        "Thermo Scientific DRI Amphetamines Assay",
        "DRI Amphetamines Assay"
    ],
    "Submitter Information": "Microgenics Corporation (Thermo Fisher Scientific, Clinical Diagnostics Division)",
    "510(k) Number": "K093114",
    "Predicate Device Reference 510(k) Number(s)": [
        "K943993"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "LAF"
    ],
    "Summary Letter Date": "May 7, 2010",
    "Summary Letter Received Date": "May 10, 2010",
    "Submission Date": "May 10, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Methamphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Methamphetamine"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Thermo Scientific DRI Amphetamines Assay for detection of amphetamine and methamphetamine in human urine using enzyme immunoassay technology.",
    "Indications for Use Summary": "For qualitative or semi-quantitative determination of amphetamine and methamphetamine in human urine; provides a preliminary analytical result and requires confirmatory testing by an alternative chemical method such as GC/MS.",
    "fda_folder": "Toxicology"
}